CASE CCC IN THE NEWS
Vaccines Might Become Another Way to Fight Cancer
MyFox Philadelphia - Jan 21, 2013
...Liau is currently researching a brain cancer treatment vaccine. Dr. Jeffrey Hardacre, who's researching a pancreatic cancer vaccine, agreed.
Who to Watch: Health Care/Dr. Marcos De Lima: Director, Hematologic Malignancies and Stem Cell Transplant Program, Seidman Cancer Center, University Hospitals
Crain's Cleveland Business - Jan 21, 2013
Dr. Marcos de Lima moved to Cleveland last summer to do here what he's known for internationally: expand bone marrow transplants to more patients and increase patients' access to clinical trials.
Crain's Cleveland Business - Who to Watch: Health Care/First Class of Harrington Scholars: Harrington Discovery Institute, University Hospitals Case Medical Center
Crain's Cleveland Business - Jan 21, 2013
Dr. Sanford Markowitz of Case Western Reserve University – the only local scientist tapped as a Harrington scholar – said getting this level of support often is difficult for physician-scientists.
Smartphone Apps Can Fall Short in Detecting Skin Cancer, Study Finds
ABC News Radio - Jan 19, 2013
Given their accessibility, these apps could hold tremendous potential once they have been evaluated, said Dr. Meg R. Gerstenblith, an assistant professor in the department of dermatology at Case Western Reserve University.
New Biostatistics and Bioinformatics Core Facility
The former Case CCC Biostatistics Core Facility has undergone some significant changes! Now called the Biostatistics and Bioinformatics Core Facility, this shared resource has brought on genetic epidemiologist and biostatistician Dr. Jill Barnholtz-Sloan as Co-Director and expanded services in bioinformatics including:
- Analysis of high throughput "omics" data, including but not limited to, array-based and next generation sequencing data; and
- Study design and protocol development for use of high throughput "omics" data in human and animal studies of cancer.
Further descriptions of services and updated policies and fees are on the Biostatistics and Bioinformatics Core Facility website. Facility Director Dr. Mark Schluchter and Co-Directors Drs. Paul Elson and Jill Barnholtz-Sloan are also available to answer your questions.
November CTSC Core Utilization Award Recipients
Congratulations to the recipients of the November CTSC Core Utilization Awards:
- Ritu Chakravarti, PhD: Identification of post-translational modifications on 14-3-3 in Vasculitis
- David Serre, PhD: Simultaneous Reconstruction of Multiple Haploid Plasmodium vivax Genomes from Complex Infections by Dilution Separation and Genome Sequencing
- Liwen Wang, PhD: HIV-1 antigen
American Cancer Society IRG Awards
The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
LOI Deadline: February 18
Application Deadline: April 5
MARK YOUR CALENDARS
Prostate Cancer Symposium
The Glickman Urological & Kidney Institute, Lerner Research Institute, and Case Comprehensive Cancer Center invite you to a symposium on The Role of Interferon in Metastasis and Resistance to DNA Damage in Prostate Cancer, February 7 in Cleveland Clinic Room Q1-300. Capacity is limited, so please register today!
TRCCC Annual Meeting: The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity
Registration is open for the 16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC),The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity. Held February 20-22 at the Seven Springs Mountain Resort in Seven Springs, PA, this meeting will feature two symposiums focused on Tumor-mediated Immune Suppression and Vaccine and Cellular Therapy, with spotlight sessions on Imaging and Viral Vectors. The agenda will also include a poster session. Researchers, institutional officials, and students are invited to submit abstracts for poster presentations by February 4.
Breast Cancer Program in Development Annual Retreat
Drs. William Schiemann and Lyndsay Harris, Co-Leaders of the Breast Cancer Program in Development, invite you to attend the program Annual Retreat on Monday, March 11 in the Dively Building on CWRU campus. The agenda and program information will be available soon.